In Brief: APhA
This article was originally published in The Tan Sheet
Executive Summary
APhA: J&J/Merck's Pepcid AC is the subject of a New Product Bulletin prepared by APhA and mailed to about 100,000 pharmacists. The publication, which explains the pharmacokinetics, dosing, efficacy, safety and adverse effects of the product, is APhA's first to address an OTC drug. The bulletin, which was sponsored by J&J/Merck, includes answers to common questions about famotidine, Pepcid AC's active ingredient...